1. Home
  2. DTE vs ALGN Comparison

DTE vs ALGN Comparison

Compare DTE & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DTE Energy Company

DTE

DTE Energy Company

HOLD

Current Price

$129.83

Market Cap

28.3B

Sector

Utilities

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$165.05

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTE
ALGN
Founded
1903
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Industrial Specialties
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3B
10.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DTE
ALGN
Price
$129.83
$165.05
Analyst Decision
Buy
Buy
Analyst Count
11
14
Target Price
$149.36
$188.92
AVG Volume (30 Days)
1.4M
1.6M
Earning Date
10-30-2025
10-29-2025
Dividend Yield
3.59%
N/A
EPS Growth
N/A
N/A
EPS
6.67
5.16
Revenue
$14,822,000,000.00
$3,982,622,000.00
Revenue This Year
$10.64
$2.58
Revenue Next Year
$4.66
$3.41
P/E Ratio
$19.46
$32.05
Revenue Growth
19.39
0.56
52 Week Low
$116.30
$122.00
52 Week High
$143.79
$241.29

Technical Indicators

Market Signals
Indicator
DTE
ALGN
Relative Strength Index (RSI) 33.36 78.33
Support Level $129.53 $144.00
Resistance Level $134.07 $166.61
Average True Range (ATR) 1.98 4.66
MACD -0.35 1.60
Stochastic Oscillator 4.68 94.04

Price Performance

Historical Comparison
DTE
ALGN

About DTE DTE Energy Company

DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: